FORMULATION AND EVALUATION OF DOXORUBICIN CONTAINING NANOGELS FOR DELIVERY TO CANCER CELLS
The objective of this study is to prepare nanogels were prepared via charged gellan gum. It was prepared by in situ cross linking reaction between two oppositely charged materials by green method without use of chemical cross linking agents. The prepared nanogels were characterized by Dynamic light scattering, scanning electron microscopy, differential scanning calorimetry and X- Ray diffractometry. The prepared formulation had average particle size of 226 nm with polydispersity index of 0.3. The doxorubicin loaded nanogel demonstrated sustained release for 20 h. The prepared nanogels were hemocompatible and cyctocompatible as revealed by hemocompatibility and MTT assay respectively. All results confirmed that these nanogels can be used for cancer treatment.
Keywords: Nanogel, Chitosan, Gellan gum, Doxorubicin, Cancer.
2. Jayakumar R, Chennazhi KP, Muzzarelli RAA, Tamura H, NairSV, Selvamurugan N. Chitosan conjugated DNA nanoparticles in gene therapy. Carbohyd Polym. 2010; 79(1):1–8.
3. Janssen PE, Lindeberg B, Sandford PA. Structural studies of gellan gum, an extra cellular polysaccharide elaborated by Pseudomonas eloda. Carbohyd Res. 1983; 124(1):135-9.
4. Malcolm A, O’Neill R, Selvendran R, Morris VJ. Structure of the acidic extracellular gelling polysaccharide produced by Pseudomonas elodea. Carbohyd Res. 1983;124(1):123–33.
5. Sasaki Y, Akiyoshi K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chemical record (New York, N.Y.) 2010; 10(6):366-76.
6. Rhee Y, Mansour HM. Nanopharmaceuticals I: nanocarrier systems in drug delivery. Int J of Nanotech. 2011; 8(1-2):84-114.
7. Wu X, Mansour HM. Nanopharmaceuticals II: application of nanoparticles and nanocarrier systems in pharmaceutics and nanomedicine. Int J of Nanotech. 2011; 8(1-2):115-45.
8. Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug discovery today. 2002; 7(10):569-79.
9. Matsumura Y, Maeda HA. New concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986; 46(12):6387-92.
10. Anitha A, Deepagan VG, Divya R VV, Deepthy M, Nair SV, Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohyd Polym. 2011; 84(3):1158-64.
11. O’Leary RR, Watkins WD, Guess WL. Comparative chemical and toxicological evaluation of residual ethylene oxide in sterilized plastics. J Pharm Sci. 1969; 58(8):1007-10.
12. Madane RG, Mahajan HS. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study. Drug Del. 2014; 23(4):1-9.
13. Zahr AS, Davis CA, Pishko MV. Macrophage uptake of core shell nanoparticles surface modified with poly (ethylene glycol). Langmuir. 2006; 22(19):8178-85.
14. Peppas NA. Analysis of fickian and non fickian drug release from polymers Pharm Acta Helv. 1985; 60:110–11.
15. Sarika PR, Nirmala RJ. Preparation and characterisation of gelatin–gum arabic aldehyde nanogels via inverse miniemulsion technique. Int Journal of Biol Mac. 2015; 76:181-7.
16. Zhao L, Feng S. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J of Pharm Sci. 2010; 99(8):3552–60.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).